Improving in vivo assays in snake venom and antivenom research: a community discussion
Guardat en:
| Autors: | , , , , |
|---|---|
| Format: | artículo original |
| Data de publicació: | 2024 |
| Descripció: | On the 26th January 2023, a free to attend, ‘improving in vivo snake venom research: a community discussion’ meeting was held virtually. This webinar brought together researchers from around the world to discuss current neutralisation of venom lethality mouse assays that are used globally to assess the efficacy of therapies for snakebite envenoming. The assay’s strengths and weaknesses were highlighted, and we discussed what improvements could be made to refine and reduce animal testing, whilst supporting preclinical antivenom and drug discovery for snakebite envenoming. This report summarises the issues highlighted, the discussions held, with additional commentary on key perspectives provided by the authors |
| Pais: | Kérwá |
| Institution: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| Idioma: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/104885 |
| Accés en línia: | https://f1000research.com/articles/13-192/v1 https://hdl.handle.net/10669/104885 https://doi.org/10.12688/f1000research.148223.1 |
| Paraula clau: | Preclinical assays Lethality 3Rs NAMs Antivenom Venom |